Mostrar el registro sencillo del ítem

dc.contributor.authorO'Higgins, Marcelo
dc.contributor.authorBenito, Ana
dc.contributor.authorReal-López, Matias
dc.contributor.authorGil-Miravet, Isis
dc.contributor.authorOchoa, Enrique
dc.contributor.authorHaro Cortés, Gonzalo
dc.date.accessioned2023-03-02T11:54:05Z
dc.date.available2023-03-02T11:54:05Z
dc.date.issued2022
dc.identifier.citationO'Higgins, M., Benito, A., Real-Lopez, M., Gil-Miravet, I., Ochoa, E., & Haro, G. (2023). Relationship of DRD5 and MAO-B VNTR polymorphisms with paranoid and antisocial personality disorders in polydrug users. Personality and Mental Health, 17(1), 77–86. https://doi.org/10.1002/pmh.1563ca_CA
dc.identifier.urihttp://hdl.handle.net/10234/201908
dc.description.abstractAlthough multiple studies have shown the role genetics plays in personality disorders and in addictions, few have studied the genetic aspects of their comorbidity. Here, we carried out a cross-sectional study in a sample comprising 303 Caucasian polydrug-consuming patients. The presence of personality disorders was evaluated using the International Personality Disorder Examination, and genes related to dopamine, serotonin and monoamine oxidase (MAO) were genotyped. A significant relationship was observed between the bp 279 DRD5 variable number of tandem repeat (VNTR) polymorphism and paranoid personality disorder OR 95 ð Þ ð Þ¼ %CI 2:186 1ð Þ :074;4:449 ;p ¼ 0:006 . The bp 182 OR 95 ð Þ ð Þ¼ %CI 0:407 0ð Þ :178;0:931 ;p ¼ 0:033 and bp 184 OR 95 ð Þ ð Þ¼ %CI 0:391 0ð Þ :188;0:813 ;p ¼ 0:012 alleles of the MAOB VNTR were also associated with antisocial personality disorder. Among patients with addictions, paranoid personality disorder should also be considered in addition to the importance of antisocial and borderline personality disorders. The higher frequency of the bp 279 DRD5 VNTR allele found in patients with paranoid personality disorder, as well as the associations between alleles of the MAOB VNTR and antisocial personality disorder, support the monoaminergic bases of these personality disorders, especially when dealing with patients with addictions.ca_CA
dc.format.extent10 p.ca_CA
dc.format.mimetypeapplication/pdfca_CA
dc.language.isoengca_CA
dc.publisherWileyca_CA
dc.relation.isPartOfPersonality and Mental Health, 2023, 17.ca_CA
dc.rightsThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. © 2022 The Authors Personality and Mental Health Published by John Wiley & Sons Ltd.ca_CA
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/ca_CA
dc.titleRelationship of DRD5 and MAO-B VNTR polymorphisms with paranoid and antisocial personality disorders in polydrug usersca_CA
dc.typeinfo:eu-repo/semantics/articleca_CA
dc.identifier.doihttps://doi.org/10.1002/pmh.1563
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca_CA
dc.relation.publisherVersionhttps://onlinelibrary.wiley.com/doi/full/10.1002/pmh.1563ca_CA
dc.type.versioninfo:eu-repo/semantics/publishedVersionca_CA
project.funder.nameFundación de Investigación del Hospital Provincial de Castellónca_CA
project.funder.nameGeneralitat Valencianaca_CA
oaire.awardNumberCS2003-05-05ca_CA
oaire.awardNumberCAF 15-049, 21-042, 21-043ca_CA
oaire.awardNumberT4591000ca_CA


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided
the original work is properly cited.
© 2022 The Authors Personality and Mental Health Published by John Wiley & Sons Ltd.
Excepto si se señala otra cosa, la licencia del ítem se describe como: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. © 2022 The Authors Personality and Mental Health Published by John Wiley & Sons Ltd.